1887

Abstract

IFN-induced transmembrane protein 3 (IFITM3) is a restriction factor that blocks cytosolic entry of numerous viruses that utilize acidic endosomal entry pathways. In humans and mice, IFITM3 limits influenza-induced morbidity and mortality. Although many IFITM3-sensitive viruses are zoonotic, whether IFITMs function as antiviral restriction factors in mammalian species other than humans and mice is unknown. Here, IFITM3 orthologues in the microbat () and pig () were identified using rapid amplification of cDNA ends. Amino acid residues known to be important for IFITM3 function were conserved in the pig and microbat orthologues. Ectopically expressed pig and microbat IFITM3 co-localized with transferrin (early endosomes) and CD63 (late endosomes/multivesicular bodies). Pig and microbat IFITM3 restricted cell entry mediated by multiple influenza haemagglutinin subtypes and lyssavirus glycoproteins. Expression of pig or microbat IFITM3 in A549 cells reduced influenza virus yields and nucleoprotein expression. Conversely, small interfering RNA knockdown of IFITM3 in pig NPTr cells and primary microbat cells enhanced virus replication, demonstrating that these genes are functional in their species of origin at endogenous levels. In summary, we showed that IFITMs function as potent broad-spectrum antiviral effectors in two mammals – pigs and bats – identified as major reservoirs for emerging viruses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.000058
2015-05-01
2019-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/5/991.html?itemId=/content/journal/jgv/10.1099/vir.0.000058&mimeType=html&fmt=ahah

References

  1. Amengual B., Bourhy H., López-Roig M., Serra-Cobo J.. ( 2007; ). Temporal dynamics of European bat Lyssavirus type 1 and survival of Myotis myotis bats in natural colonies. . PLoS ONE 2:, e566. [CrossRef] [PubMed]
    [Google Scholar]
  2. Amini-Bavil-Olyaee S., Choi Y. J., Lee J. H., Shi M., Huang I. C., Farzan M., Jung J. U.. ( 2013; ). The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. . Cell Host Microbe 13:, 452–464. [CrossRef] [PubMed]
    [Google Scholar]
  3. Anafu A. A., Bowen C. H., Chin C. R., Brass A. L., Holm G. H.. ( 2013; ). Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. . J Biol Chem 288:, 17261–17271. [CrossRef] [PubMed]
    [Google Scholar]
  4. Andersson M., Ahlberg V., Jensen-Waern M., Fossum C.. ( 2011; ). Intestinal gene expression in pigs experimentally co-infected with PCV2 and PPV. . Vet Immunol Immunopathol 142:, 72–80. [CrossRef] [PubMed]
    [Google Scholar]
  5. Badrane H., Tordo N.. ( 2001; ). Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders. . J Virol 75:, 8096–8104. [CrossRef] [PubMed]
    [Google Scholar]
  6. Bailey C. C., Huang I. C., Kam C., Farzan M.. ( 2012; ). Ifitm3 limits the severity of acute influenza in mice. . PLoS Pathog 8:, e1002909. [CrossRef] [PubMed]
    [Google Scholar]
  7. Bailey C. C., Kondur H. R., Huang I. C., Farzan M.. ( 2013; ). Interferon-induced transmembrane protein 3 is a type II transmembrane protein. . J Biol Chem 288:, 32184–32193. [CrossRef] [PubMed]
    [Google Scholar]
  8. Bean A. G., Baker M. L., Stewart C. R., Cowled C., Deffrasnes C., Wang L. F., Lowenthal J. W.. ( 2013; ). Studying immunity to zoonotic diseases in the natural host – keeping it real. . Nat Rev Immunol 13:, 851–861. [CrossRef] [PubMed]
    [Google Scholar]
  9. Biesold S. E., Ritz D., Gloza-Rausch F., Wollny R., Drexler J. F., Corman V. M., Kalko E. K., Oppong S., Drosten C., Müller M. A.. ( 2011; ). Type I interferon reaction to viral infection in interferon-competent, immortalized cell lines from the African fruit bat Eidolon helvum. . PLoS ONE 6:, e28131. [CrossRef] [PubMed]
    [Google Scholar]
  10. Bonifacino J. S., Traub L. M.. ( 2003; ). Signals for sorting of transmembrane proteins to endosomes and lysosomes. . Annu Rev Biochem 72:, 395–447. [CrossRef] [PubMed]
    [Google Scholar]
  11. Brass A. L., Huang I. C., Benita Y., John S. P., Krishnan M. N., Feeley E. M., Ryan B. J., Weyer J. L., van der Weyden L. et al. ( 2009; ). The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. . Cell 139:, 1243–1254. [CrossRef] [PubMed]
    [Google Scholar]
  12. Chen Y. X., Welte K., Gebhard D. H., Evans R. L.. ( 1984; ). Induction of T cell aggregation by antibody to a 16kd human leukocyte surface antigen. . J Immunol 133:, 2496–2501.[PubMed]
    [Google Scholar]
  13. Demaison C., Parsley K., Brouns G., Scherr M., Battmer K., Kinnon C., Grez M., Thrasher A. J.. ( 2002; ). High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. . Hum Gene Ther 13:, 803–813. [CrossRef] [PubMed]
    [Google Scholar]
  14. Drexler J. F., Corman V. M., Wegner T., Tateno A. F., Zerbinati R. M., Gloza-Rausch F., Seebens A., Müller M. A., Drosten C.. ( 2011; ). Amplification of emerging viruses in a bat colony. . Emerg Infect Dis 17:, 449–456. [CrossRef] [PubMed]
    [Google Scholar]
  15. Drexler J. F., Corman V. M., Müller M. A., Maganga G. D., Vallo P., Binger T., Gloza-Rausch F., Cottontail V. M., Rasche A. et al. ( 2012; ). Bats host major mammalian paramyxoviruses. . Nat Commun 3:, 796. [CrossRef] [PubMed]
    [Google Scholar]
  16. Drexler J. F., Corman V. M., Drosten C.. ( 2014; ). Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. . Antiviral Res 101:, 45–56. [CrossRef] [PubMed]
    [Google Scholar]
  17. Duggal N. K., Emerman M.. ( 2012; ). Evolutionary conflicts between viruses and restriction factors shape immunity. . Nat Rev Immunol 12:, 687–695. [CrossRef] [PubMed]
    [Google Scholar]
  18. Everitt A. R., Clare S., Pertel T., John S. P., Wash R. S., Smith S. E., Chin C. R., Feeley E. M., Sims J. S. et al. ( 2012; ). IFITM3 restricts the morbidity and mortality associated with influenza. . Nature 484:, 519–523. [CrossRef] [PubMed]
    [Google Scholar]
  19. Everitt A. R., Clare S., McDonald J. U., Kane L., Harcourt K., Ahras M., Lall A., Hale C., Rodgers A. et al. ( 2013; ). Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. . PLoS ONE 8:, e80723. [CrossRef] [PubMed]
    [Google Scholar]
  20. Fadel H. J., Poeschla E. M.. ( 2011; ). Retroviral restriction and dependency factors in primates and carnivores. . Vet Immunol Immunopathol 143:, 179–189. [CrossRef] [PubMed]
    [Google Scholar]
  21. Feeley E. M., Sims J. S., John S. P., Chin C. R., Pertel T., Chen L. M., Gaiha G. D., Ryan B. J., Donis R. O. et al. ( 2011; ). IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. . PLoS Pathog 7:, e1002337. [CrossRef] [PubMed]
    [Google Scholar]
  22. Ferrara F., Molesti E., Böttcher-Friebertshäuser E., Cattoli G., Corti D., Scott S. D., Temperton N. J.. ( 2012; ). The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes. . J Mol Genet Med 7:, 309–314.[PubMed]
    [Google Scholar]
  23. Ferrari M., Scalvini A., Losio M. N., Corradi A., Soncini M., Bignotti E., Milanesi E., Ajmone-Marsan P., Barlati S. et al. ( 2003; ). Establishment and characterization of two new pig cell lines for use in virological diagnostic laboratories. . J Virol Methods 107:, 205–212. [CrossRef] [PubMed]
    [Google Scholar]
  24. Friedman R. L., Manly S. P., McMahon M., Kerr I. M., Stark G. R.. ( 1984; ). Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. . Cell 38:, 745–755. [CrossRef] [PubMed]
    [Google Scholar]
  25. Gouy M., Guindon S., Gascuel O.. ( 2010; ). SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. . Mol Biol Evol 27:, 221–224. [CrossRef] [PubMed]
    [Google Scholar]
  26. Hickford D., Frankenberg S., Shaw G., Renfree M. B.. ( 2012; ). Evolution of vertebrate interferon inducible transmembrane proteins. . BMC Genomics 13:, 155. [CrossRef] [PubMed]
    [Google Scholar]
  27. Huang I. C., Bailey C. C., Weyer J. L., Radoshitzky S. R., Becker M. M., Chiang J. J., Brass A. L., Ahmed A. A., Chi X. et al. ( 2011; ). Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. . PLoS Pathog 7:, e1001258. [CrossRef] [PubMed]
    [Google Scholar]
  28. Jia R., Pan Q., Ding S., Rong L., Liu S. L., Geng Y., Qiao W., Liang C.. ( 2012; ). The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. . J Virol 86:, 13697–13707. [CrossRef] [PubMed]
    [Google Scholar]
  29. John S. P., Chin C. R., Perreira J. M., Feeley E. M., Aker A. M., Savidis G., Smith S. E., Elia A. E., Everitt A. R. et al. ( 2013; ). The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. . J Virol 87:, 7837–7852. [CrossRef] [PubMed]
    [Google Scholar]
  30. Kirmaier A., Wu F., Newman R. M., Hall L. R., Morgan J. S., O’Connor S., Marx P. A., Meythaler M., Goldstein S. et al. ( 2010; ). TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. . PLoS Biol 8:, e1000462. [CrossRef] [PubMed]
    [Google Scholar]
  31. Kupferschmidt K.. ( 2013; ). Emerging infectious diseases. Link to MERS virus underscores bats’ puzzling threat. . Science 341:, 948–949. [CrossRef] [PubMed]
    [Google Scholar]
  32. Li K., Markosyan R. M., Zheng Y. M., Golfetto O., Bungart B., Li M., Ding S., He Y., Liang C. et al. ( 2013; ). IFITM proteins restrict viral membrane hemifusion. . PLoS Pathog 9:, e1003124. [CrossRef] [PubMed]
    [Google Scholar]
  33. Lu J., Pan Q., Rong L., He W., Liu S. L., Liang C.. ( 2011; ). The IFITM proteins inhibit HIV-1 infection. . J Virol 85:, 2126–2137. [CrossRef] [PubMed]
    [Google Scholar]
  34. Matrosovich M., Matrosovich T., Garten W., Klenk H. D.. ( 2006; ). New low-viscosity overlay medium for viral plaque assays. . Virol J 3:, 63. [CrossRef] [PubMed]
    [Google Scholar]
  35. McNatt M. W., Zang T., Hatziioannou T., Bartlett M., Fofana I. B., Johnson W. E., Neil S. J., Bieniasz P. D.. ( 2009; ). Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. . PLoS Pathog 5:, e1000300. [CrossRef] [PubMed]
    [Google Scholar]
  36. Miller L. C., Jiang Z., Sang Y., Harhay G. P., Lager K. M.. ( 2014; ). Evolutionary characterization of pig interferon-inducible transmembrane gene family and member expression dynamics in tracheobronchial lymph nodes of pigs infected with swine respiratory disease viruses. . Vet Immunol Immunopathol 159:, 180–191. [CrossRef] [PubMed]
    [Google Scholar]
  37. Moffatt P., Gaumond M. H., Salois P., Sellin K., Bessette M. C., Godin E., de Oliveira P. T., Atkins G. J., Nanci A., Thomas G.. ( 2008; ). Bril: a novel bone-specific modulator of mineralization. . J Bone Miner Res 23:, 1497–1508. [CrossRef] [PubMed]
    [Google Scholar]
  38. Mudhasani R., Tran J. P., Retterer C., Radoshitzky S. R., Kota K. P., Altamura L. A., Smith J. M., Packard B. Z., Kuhn J. H. et al. ( 2013; ). IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. . J Virol 87:, 8451–8464. [CrossRef] [PubMed]
    [Google Scholar]
  39. Omatsu T., Bak E. J., Ishii Y., Kyuwa S., Tohya Y., Akashi H., Yoshikawa Y.. ( 2008; ). Induction and sequencing of Rousette bat interferon α and β genes. . Vet Immunol Immunopathol 124:, 169–176. [CrossRef] [PubMed]
    [Google Scholar]
  40. Papenfuss A. T., Baker M. L., Feng Z. P., Tachedjian M., Crameri G., Cowled C., Ng J., Janardhana V., Field H. E., Wang L. F.. ( 2012; ). The immune gene repertoire of an important viral reservoir, the Australian black flying fox. . BMC Genomics 13:, 261. [CrossRef] [PubMed]
    [Google Scholar]
  41. Perreira J. M., Chin C. R., Feeley E. M., Brass A. L.. ( 2013; ). IFITMs restrict the replication of multiple pathogenic viruses. . J Mol Biol 425:, 4937–4955. [CrossRef] [PubMed]
    [Google Scholar]
  42. Provost C., Jia J. J., Music N., Lévesque C., Lebel M. E., del Castillo J. R., Jacques M., Gagnon C. A.. ( 2012; ). Identification of a new cell line permissive to porcine reproductive and respiratory syndrome virus infection and replication which is phenotypically distinct from MARC-145 cell line. . Virol J 9:, 267. [CrossRef] [PubMed]
    [Google Scholar]
  43. Quan P. L., Firth C., Conte J. M., Williams S. H., Zambrana-Torrelio C. M., Anthony S. J., Ellison J. A., Gilbert A. T., Kuzmin I. V. et al. ( 2013; ). Bats are a major natural reservoir for hepaciviruses and pegiviruses. . Proc Natl Acad Sci U S A 110:, 8194–8199. [CrossRef] [PubMed]
    [Google Scholar]
  44. Seim I., Fang X., Xiong Z., Lobanov A. V., Huang Z., Ma S., Feng Y., Turanov A. A., Zhu Y. et al. ( 2013; ). Genome analysis reveals insights into physiology and longevity of the Brandt’s bat Myotis brandtii. . Nat Commun 4:, 2212. [CrossRef] [PubMed]
    [Google Scholar]
  45. Shan Z., Han Q., Nie J., Cao X., Chen Z., Yin S., Gao Y., Lin F., Zhou X. et al. ( 2013; ). Negative regulation of interferon-induced transmembrane protein 3 by SET7-mediated lysine monomethylation. . J Biol Chem 288:, 35093–35103. [CrossRef] [PubMed]
    [Google Scholar]
  46. Siegrist F., Ebeling M., Certa U.. ( 2011; ). The small interferon-induced transmembrane genes and proteins. . J Interferon Cytokine Res 31:, 183–197.
    [Google Scholar]
  47. Smith I., Wang L. F.. ( 2013; ). Bats and their virome: an important source of emerging viruses capable of infecting humans. . Curr Opin Virol 3:, 84–91.
    [Google Scholar]
  48. Smith S. E., Gibson M. S., Wash R. S., Ferrara F., Wright E., Temperton N., Kellam P., Fife M.. ( 2013; ). Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro. . J Virol 87:, 12957–12966. [CrossRef] [PubMed]
    [Google Scholar]
  49. Smith S., Weston S., Kellam P., Marsh M.. ( 2014; ). IFITM proteins-cellular inhibitors of viral entry. . Curr Opin Virol 4:, 71–77.
    [Google Scholar]
  50. Takahashi S., Doss C., Levy S., Levy R.. ( 1990; ). TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. . J Immunol 145:, 2207–2213.[PubMed]
    [Google Scholar]
  51. Tong S., Zhu X., Li Y., Shi M., Zhang J., Bourgeois M., Yang H., Chen X., Recuenco S. et al. ( 2013; ). New World bats harbor diverse influenza A viruses. . PLoS Pathog 9:, e1003657. [CrossRef] [PubMed]
    [Google Scholar]
  52. Wang Z., Zhang A., Wan Y., Liu X., Qiu C., Xi X., Ren Y., Wang J., Dong Y. et al. ( 2014; ). Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. . Proc Natl Acad Sci U S A 111:, 769–774. [CrossRef] [PubMed]
    [Google Scholar]
  53. Warren C. J., Griffin L. M., Little A. S., Huang I. C., Farzan M., Pyeon D.. ( 2014; ). The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus. . PLoS ONE 9:, e96579. [CrossRef] [PubMed]
    [Google Scholar]
  54. Weidner J. M., Jiang D., Pan X. B., Chang J., Block T. M., Guo J. T.. ( 2010; ). Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. . J Virol 84:, 12646–12657. [CrossRef] [PubMed]
    [Google Scholar]
  55. Wright E., Temperton N. J., Marston D. A., McElhinney L. M., Fooks A. R., Weiss R. A.. ( 2008; ). Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. . J Gen Virol 89:, 2204–2213. [CrossRef] [PubMed]
    [Google Scholar]
  56. Yount J. S., Moltedo B., Yang Y. Y., Charron G., Moran T. M., López C. B., Hang H. C.. ( 2010; ). Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. . Nat Chem Biol 6:, 610–614. [CrossRef] [PubMed]
    [Google Scholar]
  57. Yount J. S., Karssemeijer R. A., Hang H. C.. ( 2012; ). S-Palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. . J Biol Chem 287:, 19631–19641. [CrossRef] [PubMed]
    [Google Scholar]
  58. Zhang Z., Liu J., Li M., Yang H., Zhang C.. ( 2012; ). Evolutionary dynamics of the interferon-induced transmembrane gene family in vertebrates. . PLoS ONE 7:, e49265. [CrossRef] [PubMed]
    [Google Scholar]
  59. Zhang G., Cowled C., Shi Z., Huang Z., Bishop-Lilly K. A., Fang X., Wynne J. W., Xiong Z., Baker M. L. et al. ( 2013; a). Comparative analysis of bat genomes provides insight into the evolution of flight and immunity. . Science 339:, 456–460. [CrossRef] [PubMed]
    [Google Scholar]
  60. Zhang Y. H., Zhao Y., Li N., Peng Y. C., Giannoulatou E., Jin R. H., Yan H. P., Wu H., Liu J. H. et al. ( 2013; b). Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. . Nat Commun 4:, 1418. [CrossRef] [PubMed]
    [Google Scholar]
  61. Zhao X., Guo F., Liu F., Cuconati A., Chang J., Block T. M., Guo J. T.. ( 2014; ). Interferon induction of IFITM proteins promotes infection by human coronavirus OC43. . Proc Natl Acad Sci U S A 111:, 6756–6761. [CrossRef] [PubMed]
    [Google Scholar]
  62. Zhou P., Cowled C., Todd S., Crameri G., Virtue E. R., Marsh G. A., Klein R., Shi Z., Wang L. F., Baker M. L.. ( 2011; ). Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity. . J Immunol 186:, 3138–3147. [CrossRef] [PubMed]
    [Google Scholar]
  63. Zhou P., Cowled C., Wang L. F., Baker M. L.. ( 2013; ). Bat Mx1 and Oas1, but not Pkr are highly induced by bat interferon and viral infection. . Dev Comp Immunol 40:, 240–247. [CrossRef] [PubMed]
    [Google Scholar]
  64. Zufferey R., Nagy D., Mandel R. J., Naldini L., Trono D.. ( 1997; ). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. . Nat Biotechnol 15:, 871–875. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.000058
Loading
/content/journal/jgv/10.1099/vir.0.000058
Loading

Data & Media loading...

Supplements

Supplementary Data



PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error